NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $10.27 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2023-02-24
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $10.27, a 7.20% increase from fiscal 2021.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $9.58, a 86.38% increase from fiscal 2020.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2020 was $5.14, a 25.67% increase from fiscal 2019.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2019 was $4.09, a 37.71% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2022-12-31 | $10.27 10-K · filed 2023-02-24 |
| 2021-12-31 | $9.58 10-K · filed 2022-02-25 |
| 2020-12-31 | $5.14 10-K · filed 2021-02-25 |
| 2019-12-31 | $4.09 10-K · filed 2020-02-28 |
| 2018-12-31 | $2.97 10-K · filed 2019-02-26 |
| 2017-12-31 | $2.38 10-K · filed 2018-03-13 |
| 2016-12-31 | $1.48 10-K · filed 2017-03-14 |
| 2015-12-31 | $1.39 10-K · filed 2016-04-18 |
| 2014-12-31 | $0.85 10-K · filed 2015-03-03 |
| 2013-12-31 | $0.57 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |